Fenbendazole 1000 mg

Fenbendazole is a broad-spectrum benzimidazole anthelmintic used in veterinary medicine. The exact approved parasite claims depend on the animal species and product label.

• Veterinary fenbendazole products are used against roundworms, hookworms and whipworms in appropriate animal species.

• Certain products are also labeled for selected tapeworms and other susceptible parasites.

• FDA-approved Panacur C for dogs is labeled for roundworms, hookworms, whipworms and Taenia pisiformis tapeworms.

• FDA-approved fenbendazole products also exist for cattle and goats, with species-specific parasite indications.

Because the exact regulatory label for this 1000 mg tablet has not been verified, these established fenbendazole uses should not be interpreted as proof that every parasite or every animal species is covered by this particular product.

Fenbendazole interferes with tubulin and microtubule formation in susceptible parasites. This disrupts essential cellular processes, including nutrient utilization and energy metabolism, eventually leading to parasite death.

Its activity is directed toward susceptible parasitic organisms rather than bacteria or viruses. Treatment effectiveness can also be affected by parasite species, resistance and whether the product is administered at the correct species-specific dose.

Veterinary labels therefore emphasize appropriate dosing and diagnosis rather than treating every animal or every suspected worm infection with the same amount.

There is no universal dose for a 1000 mg fenbendazole tablet. The correct amount depends on species, body weight, parasite and the particular veterinary product.

Factor	Why it matters
Animal species	Approved uses and dose schedules differ between dogs, cattle, goats, horses and other animals
Body weight	Fenbendazole treatment is commonly weight-based
Parasite	Different parasites may require different treatment durations
Product formulation	A 1000 mg tablet cannot automatically be substituted for a powder, suspension or granule
Food-producing animals	Withdrawal periods may apply

For example, the FDA-approved Panacur C canine label uses 50 mg/kg daily for 3 consecutive days, whereas FDA-approved cattle/goat fenbendazole products use different species-specific regimens. These examples must not be used to calculate a dose for this particular 1000 mg tablet.

Do not give one or more 1000 mg tablets based solely on the tablet strength. A veterinarian should determine the appropriate treatment.

Use Fenbendazole 1000 mg only according to the instructions applicable to the animal and the supplied product label.

• Confirm the animal species and current body weight before treatment.

• Use the product only for parasites for which fenbendazole is appropriate.

• Do not substitute a 1000 mg tablet for another fenbendazole formulation without veterinary confirmation.

• Do not extend treatment beyond the recommended duration.

• Do not combine it with another dewormer simply because the other medicine targets parasites.

• For food-producing animals, follow all applicable withdrawal instructions.

If the animal is unwell, pregnant, very young, elderly or receiving other medicines, veterinary advice should be obtained before treatment.

Fenbendazole is generally well tolerated when used according to an appropriate veterinary label, but adverse effects can occur.

For the FDA-approved canine product Panacur C, vomiting occurred in approximately 1% of dogs in U.S. clinical studies.

More serious problems have been associated with extra-label prolonged fenbendazole treatment in dogs. FDA reported cases of bone-marrow hypoplasia and pancytopenia following treatment longer than the labeled duration.

Store the tablets according to the actual package instructions, protected from unsuitable heat and moisture and away from children and animals that should not receive them. Because the manufacturer and exact pack insert for the Ivermectinkart 1000 mg listing have not been verified, an exact storage temperature should not be invented.

Fenbendazole is a veterinary medicine and should not be marketed or presented as an approved human medicine. FDA identifies fenbendazole as an active ingredient in approved animal drugs, and current FDA information describes approved uses in animals such as dogs, cattle and goats.

Do not use a veterinary fenbendazole 1000 mg tablet for yourself or another person. Fenbendazole has not been approved by the FDA for human use. Human cancer-treatment claims circulating online are not established clinical indications; the American Cancer Society states that fenbendazole has not been tested adequately in humans and is not FDA-approved for human use.

Veterinary treatment should account for species, body weight, parasite, pregnancy status, other medicines and whether the animal is intended for food production. Food-producing animals may have legally required withdrawal periods that vary by product and species.

Seek veterinary attention if an animal develops persistent vomiting, severe weakness, abnormal behavior, neurological signs or another serious reaction after treatment.

This information is for general education and does not replace advice from a veterinarian or qualified animal-health professional.